DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
222	一次性ネフローゼ症候群	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00404833 (ClinicalTrials.gov)	January 2003	27/11/2006	Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental	A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Conventional Immunosuppressive Treatment on Proteinuria in Idiopathic Membranous Nephropathy (MN) and Focal Segmental Glomerulosclerosis (FSGS)	Glomerulonephritis, Membranous;Glomerulosclerosis, Focal	Drug: prednisolone and mycophenolate mofetil;Drug: prednisolone and chlorambucil	Hospital Authority, Hong Kong	The University of Hong Kong	Completed	18 Years	65 Years	Both	16	Phase 3	China

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00404833
(ClinicalTrials.gov)

January 2003

27/11/2006

Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental

A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Conventional Immunosuppressive Treatment on Proteinuria in Idiopathic Membranous Nephropathy (MN) and Focal Segmental Glomerulosclerosis (FSGS)

Glomerulonephritis, Membranous;Glomerulosclerosis, Focal

Drug: prednisolone and mycophenolate mofetil;Drug: prednisolone and chlorambucil

Hospital Authority, Hong Kong

The University of Hong Kong

Completed

18 Years

65 Years

Both

Phase 3

China